Favorable Outcomes in Elderly Patients Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma

High-dose therapy and autologous stem cell transplantation (HDT-ASCT) can offer potential long-term remission or cure in patients with non-Hodgkin lymphoma (NHL). Limited experience is available on the safety and efficacy of HDT-ASCT in elderly patients. This is a single-center, retrospective study...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Dahi, Parastoo B., Tamari, Roni, Devlin, Sean M., Maloy, Molly, Bhatt, Valkal, Scordo, Michael, Goldberg, Jenna, Zelenetz, Andrew D., Hamlin, Paul A., Matasar, Matthew J., Maragulia, Jocelyn, Giralt, Sergio A., Perales, Miguel-Angel, Moskowitz, Craig H., Sauter, Craig S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5480286/
https://ncbi.nlm.nih.gov/pubmed/25175794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.08.019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados